Accredited E-Newsletter Series
|Individualized Treatment Approaches in Patients with Newly Diagnosed Hodgkin Lymphoma|
Alison J. Moskowitz, MD
|Release Date: September 10, 2018|
Expiration Date: September 10, 2019
|The management of patients with newly diagnosed Hodgkin lymphoma (HL) continues to evolve as new therapies and treatment approaches are being investigated and introduced. This activity will review helpful, evidence-based strategies for individualizing therapy in the frontline setting by describing emerging treatment regimens for newly diagnosed HL and the latest clinical data regarding these options.|
Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Bristol-Myers Squibb, Merck & Co., Inc., and Seattle Genetics, Inc.
|Begin, Earn CreditView Only, No Credit|